CN105250473A - Traditional Chinese medicine composition for protecting liver - Google Patents
Traditional Chinese medicine composition for protecting liver Download PDFInfo
- Publication number
- CN105250473A CN105250473A CN201510846160.2A CN201510846160A CN105250473A CN 105250473 A CN105250473 A CN 105250473A CN 201510846160 A CN201510846160 A CN 201510846160A CN 105250473 A CN105250473 A CN 105250473A
- Authority
- CN
- China
- Prior art keywords
- liver
- chinese medicine
- medicine composition
- traditional chinese
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for protecting the liver. The traditional Chinese medicine composition is prepared from, by mass, 20-30 parts of schisandra chinensis, 20-40 parts of ligusticum wallichii, 10-20 parts of pseudo-ginseng and 20-40 parts of oriental wormwood. The traditional Chinese medicine composition has the effect of protecting the liver and is free of obvious toxic and side effects.
Description
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of Chinese medicine composition for hepatoprotective.
Background technology
Liver is the important metabolic organ of body, and it all plays an important role in the substance metabolismes such as sugar, lipid, protein, vitamin, hormone, bile pigments, and liver also has the function of the aspects such as secretion, excretion, biological conversion simultaneously.Containing abundant enzyme in hepatocyte, and synthesize many enzymes and various thrombin, store and release Hemopoietic factor, participate in blood coagulation and hematopoiesis.Liver is also the barrier organ of body, and its removing toxic substances and phagocytic function have important protective effect to body.The then dysbolismus when liver function damage is hindered, and affect other organs function, seriously then threat to life.Liver has Hepatic artery and pylic double blood supply, and has a large amount of blood sinus, and directly and contacting blood, the permeability of liver plasma membrane is comparatively large simultaneously, therefore often carries out active effective mass exchange between hepatocyte and blood for liver plasma membrane.
Virus, medicine and noxious substance, autoimmune hepatitis etc. all can cause hepatic necrosis.Research shows, when remaining liver cell regeneration in hepatic necrosis, then often with liver interstitial proliferation, namely causes hepatic fibrosis and liver cirrhosis.When liver cirrhosis, venous blood flow is obstructed, and causes hepatic vein and portal hypertension, promotes the formation that in liver, arteriovenous anastomosis is propped up, causes hepatocyte blood supply to reduce, and then hepatocellular degeneration and necrosis occurs, fibroplasia, and liver cirrhosis is more serious, causes vicious cycle.When liver major injury, compensatory capacity significantly weakens, then occur serious hepatic insufficiency, be further development of hepatic failure, and and then cause central nervous system dysfunction, there is hepatic coma.Various injurious factor and material, as virus, medicine, ethanol etc. all can excite hepatocyte to damage, and produce a series of medium, cause hepatic necrosis, inflammation, Fibrotic pathological process, finally cause various hepatic disease.
Research finds that Cordyceps has liver-protective effect, can prevent hepatocyte spotty necrosis and focal necrosis.The Radix Astragali can make rat liver fibrosis degree obviously reduce, and reduces total collagen I, the deposition of III, IV Collagen Type VI in liver.Radix Salviae Miltiorrhizae is a kind of up-and-coming anti-liver injury Chinese medicine, and its mechanism of action is many-sided, and as improved microcirculation in liver, anti-lipid peroxidation, protection hepatocyte, promotes the collagen degradation of deposition and heavily absorb.Radix Notoginseng has effect of activating blood circulation to dissipate blood stasis, can suppress the activity of fibroblast and Ito cell in liver, reduces the generation of collagen fiber.In addition, the anti-liver injury of the Chinese medicine such as Radix Glycyrrhizae, Poria, Fructus Schisandrae Chinensis, Radix Bupleuri, Flos Carthami, Herba Sedi, Herba Silybi mariani acts in experimentation and have also been obtained confirmation.
Summary of the invention
Comprehensive state of the art and Problems existing, the object of the present invention is to provide a kind of Chinese medicine composition for hepatoprotective, the present invention is pure Chinese medicinal preparation, has the effect of hepatoprotective, without obvious toxic-side effects.
For achieving the above object, the present invention is made up of the raw material of following masses ratio: Fructus Schisandrae Chinensis 20-30 part, Rhizoma Chuanxiong 20-40 part, Radix Notoginseng 10-20 part, Herba Artemisiae Scopariae 20-40 part.Form of administration preferred oral preparation of the present invention.
Detailed description of the invention
Embodiment 1. the present invention be made up of the raw material of following masses ratio: Fructus Schisandrae Chinensis 30 parts, Rhizoma Chuanxiong 40 parts, Radix Notoginseng 10 parts, Herba Artemisiae Scopariae 40 parts.
Embodiment 2. the present invention be made up of the raw material of following masses ratio: Fructus Schisandrae Chinensis 20 parts, Rhizoma Chuanxiong 20 parts, Radix Notoginseng 20 parts, Herba Artemisiae Scopariae 20 parts.
Claims (1)
1. for the Chinese medicine composition of hepatoprotective, be made up of the raw material of following masses ratio: Fructus Schisandrae Chinensis 20-30 part, Rhizoma Chuanxiong 20-40 part, Radix Notoginseng 10-20 part, Herba Artemisiae Scopariae 20-40 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510846160.2A CN105250473A (en) | 2015-11-27 | 2015-11-27 | Traditional Chinese medicine composition for protecting liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510846160.2A CN105250473A (en) | 2015-11-27 | 2015-11-27 | Traditional Chinese medicine composition for protecting liver |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105250473A true CN105250473A (en) | 2016-01-20 |
Family
ID=55090603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510846160.2A Pending CN105250473A (en) | 2015-11-27 | 2015-11-27 | Traditional Chinese medicine composition for protecting liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105250473A (en) |
-
2015
- 2015-11-27 CN CN201510846160.2A patent/CN105250473A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 董明慧等: "具有保肝作用的临床常用中药", 《中医药导报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1186071C (en) | Medicines composition for treating chronic heart failure and its prepn | |
| CN103120742B (en) | Traditional Chinese medicine capsule for treating fatty liver and alcoholic liver and preparation method thereof | |
| CA2685684C (en) | Use of a botanical composition in preparing pharmaceutical preparation for treatment of cirrhotic portal hypertension | |
| Ren et al. | Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis | |
| CN105168142A (en) | Preparation method and application of stem type traditional Chinese medicinal material granules | |
| CN105497515B (en) | A kind of two ginseng composition of smart stilbene with oxygen lack resistant function | |
| CN105267303A (en) | Traditional Chinese medicine composition used for protecting livers | |
| CN105395678A (en) | Liver protection medicine | |
| CN105125408A (en) | Preparation method and application of rhizome traditional Chinese medicinal material decocting-free preparation | |
| CN105311208A (en) | Traditional Chinese medicine composition used for protecting livers | |
| CN105250361A (en) | Traditional Chinese medicine composition capable of protecting liver | |
| CN105250473A (en) | Traditional Chinese medicine composition for protecting liver | |
| CN105311577A (en) | Traditional Chinese medicine for protecting liver | |
| CN105267272A (en) | Traditional Chinese medicine used for protecting livers | |
| CN100428944C (en) | Compound traditional Chinese medicine for improving eyesight and its prepn. method | |
| CN105362447A (en) | Traditional Chinese medicine composition with function of liver protection | |
| CN105311154A (en) | Traditional Chinese medicine composition and application | |
| CN105267887A (en) | Liver protecting medicine composition | |
| CN105287855A (en) | Liver-protection traditional Chinese medicine composition | |
| CN102139006A (en) | Compound picrorhiza rhizome composition for treating hepatic injury and preparation method and application thereof | |
| CN105287856A (en) | Liver protection medicine | |
| CN102688407B (en) | Chinese medicinal composition for treating chronic heart failure | |
| CN102552711B (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103142695B (en) | Pharmaceutical composition for prevention and treatment of chronic glomerular diseases and preparation method of pharmaceutical composition | |
| CN1319578C (en) | Prescription of Chinese medicine compound preparation, its preparation method and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160120 |
|
| WD01 | Invention patent application deemed withdrawn after publication |